Biotech | March 06, 2026
FUJIFILM Biotechnologies launches purification technology for biologics
ShunzymeX leverages a proprietary protease to streamline purification
ShunzymeX leverages a proprietary protease to streamline purification
The decision marks a pivotal moment for the Massachusetts-based biotech giant
Nadda underlined that India’s policy framework is aligned with this transformation
The NIRSE-GAL study, conducted in Galicia, Spain, is the first real-world, population-based investigation of a universal RSV immunization program spanning two consecutive seasons
BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
As CRISPR and prime editing applications advance, researchers increasingly rely on longer guide RNAs to boost editing efficiency and reduce off-target effects
Over a two-decade career, Dr. Berman has worked on more than a dozen clinical-stage immunotherapies, including senior leadership roles in developing four oncology biologics
The Poultry Healthcare Division delivered a strong performance, posting 32% revenue growth in Q3 FY26 and 17% growth over the nine-month period
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
Subscribe To Our Newsletter & Stay Updated
